发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 144 |
| CHINA MAINLAND | 79 |
| Italy | 59 |
| GERMANY (FED REP GER) | 31 |
| England | 22 |
| Spain | 22 |
| Iran | 21 |
| France | 19 |
| Lebanon | 17 |
| Canada | 15 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| ZHENGZHOU UNIVERSITY | 17 |
| UNIVERSITY OF PARMA | 16 |
| UNIVERSITY OF TEXAS SYSTEM | 12 |
| ST JOSEPH UNIV | 11 |
| HARVARD UNIVERSITY | 10 |
| MAYO CLINIC | 9 |
| TEHRAN UNIVERSITY OF MEDICAL SCIENCES | 9 |
| UNICANCER | 8 |
| UNIVERSITY OF BOLOGNA | 8 |
| JOHNS HOPKINS UNIVERSITY | 7 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Pembrolizumab as first-line therapy for metastatic non-s... | 25 |
| Re-education of macrophages as a therapeutic strategy in... | 22 |
| Ruxolitinib for the treatment of patients with steroid-r... | 21 |
| Gold nanoparticles-mediated photothermal therapy and imm... | 20 |
| Future perspectives of therapeutic monoclonal antibodies | 14 |
| Enhancing tumor T cell infiltration to enable cancer imm... | 14 |
| Talimogene laherparepvec: review of its mechanism of act... | 14 |
| Dual role of macrophage in tumor immunity | 14 |
| Programmed cell death-1/programmed cell death ligand-1 c... | 14 |
| CD73: an emerging checkpoint for cancer immunotherapy | 14 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| FRONT IMMUNOL | 81 |
| IMMUNOTHERAPY-UK | 65 |
| CANCERS | 61 |
| INT J MOL SCI | 50 |
| J IMMUNOTHER CANCER | 31 |
| FRONT ONCOL | 24 |
| ONCOIMMUNOLOGY | 22 |
| SCI REP-UK | 22 |
| J CELL PHYSIOL | 17 |
| CLIN CANCER RES | 16 |